Chemonucleolysis Requires Chymopapain: Should We Accept Its Unavailability?

Desert Institute for Spine Care logo

The production of chymopapain and its availability in the United States and Europe has been discontinued by its manufacturer. This creates an untenable and unacceptable situation. Our patients are wit

Previous ArticleMicrotherapy in Low Back Pain Next ArticleMinimally Invasive Techniques for the Management of Lumbar Disc Herniation